anti- NFATC3 antibody

anti- NFATC3 antibody

Pida mas información

935106861

info@markelab.com

Precio

Precio a consultar

Antibody anti-NFATC3

proveedor

FineTest

reference

FNab10459

Tested Applications

ELISA, IHC, WB

reactivity

human

status

RUO

clonality

polyclonal

Descripción

Acts as a regulator of transcriptional activation. Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2.

Características del producto

category

Primary Antibodies


clonality

polyclonal


reactivity

human


immunogen target

nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3


host

Rabbit


isotype

IgG


conjugation

Unconjugated


form

liquid


tested applications

ELISA, IHC, WB


observerd MW

130-170 kDa


purity

≥95% as determined by SDS-PAGE


purification

Immunogen affinity purified


recommended dilution

WB: 1:200-1:2000; IHC: 1:50-1:200


size 1

100µg


storage

PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20℃ for 12 months(Avoid repeated freeze / thaw cycles.)


or code

NFATC3


alias

NF AT4, NF ATc3, NFAT4, NFATC3, NFATX


note

This product is for research use only.


Quizá le pueda interesar

anti- NFATC3 antibody

anti- NFATC3 antibody

proveedor

FineTest

reference

FNab05691

Tested Applications

ELISA, IHC, WB, IP

reactivity

human,mouse,rat

status

RUO

clonality

polyclonal

Acts as a regulator of transcriptional activation. Plays a role in the inducible expression of cytokine genes in T-cells...

Precio a consultar

Ver más

anti- NFATC3 antibody

anti- NFATC3 antibody

proveedor

FineTest

reference

FNab10459

Tested Applications

ELISA, IHC, WB

reactivity

human

status

RUO

clonality

polyclonal

Acts as a regulator of transcriptional activation. Plays a role in the inducible expression of cytokine genes in T-cells...

Precio a consultar

Ver más

Recombinant Human NFATC3

Recombinant Human NFATC3

proveedor

FineTest

reference

P0666

Tested Applications

Western Blot, ELISA

status

RUO

Precio a consultar

Ver más